Dr Vanessa Vaughan

STAFF PROFILE

Position

Associate Lecturer in Medicine

Faculty

Faculty of Health

Department

School of Medicine

Campus

Geelong Waurn Ponds Campus

Contact

v.vaughan@deakin.edu.au
+61 3 522 72055

Research interests

  • Cancer Cachexia
  • Multidisciplinary prevention and treatment strategies for chronic inflammatory disease
  • Molecular markers of oxidative stress and muscle metabolism

Conferences

  • Vaughan VC, Farrell H, Martin P, Lewandowski PA. PG-SGA: The use of a nutrition assessment tool for triage in an interdisciplinary cancer cachexia clinic. Annual Scientific Meeting of the Nutrition Society of Australia, Hobart, Australia, 2014
  • Vaughan VC, Hinch ECA, Sullivan-Gunn MJ, Martin P, Lewandowski PA. The role of reactive oxygen species and xanthine oxidase in the development and progression of cancer-induced cachexia. 7th Cachexia Conference, Kobe, Japan, 2013
  • Vaughan VC, Farrell H, Martin P, Lewandowski PA. Characterisation of a patient population presenting to an interdisciplinary cancer cachexia clinic in regional Victoria. 7th Cachexia Conference, Kobe, Japan, 2013
  • Vaughan VC, Farrell H, Martin P, Lewandowski PA. Characterisation of a patient population presenting to an interdisciplinary cancer cachexia clinic in regional Victoria. Australian Palliative Care Conference, Canberra, Australia, 2013
  • Vaughan VC, Hinch E, Sullivan-Gunn M, Martin P, Lewandowski PA. Eicosapentaenoic Acid in the treatment of skeletal muscle wasting in cancer-induced cachexia. 10th Congress of the International Society for the Study of Fatty Acids & Lipids, Vancouver, Canada, 2012.
  • Vaughan VC, Hinch E, Sullivan-Gunn M, Martin P, Lewandowski PA. Oxypurinol and Eicosapentaenoic Acid in the treatment of muscle wasting in cancer cachexia. 6th Cachexia Conference, Milan, Italy, 2011
  • Vaughan VC, Hinch E, Sullivan-Gunn M, Martin P, Lewandowski PA. Eicosapentaenoic acid in the treatment of skeletal muscle wasting in cancer cachexia. Joint Annual Scientific Meeting of the Nutrition Society of New Zealand and the Nutrition Society of Australia, Queenstown, New Zealand, 2011
  • Vaughan VC, Hinch E, Sullivan-Gunn M, Lewandowski PA. Oxypurinol and eicosapentaenoic acid in the treatment of skeletal muscle wasting in cancer cachexia. 23rd Lorne Cancer Conference, Lorne, Australia, 2011

Publications

Filter by

2013

Cancer cachexia: Impact, mechanisms and emerging treatments

V Vaughan, P Martin, P Lewandowski

(2013), Vol. 4, pp. 95-109, Journal of Cachexia, Sarcopenia and Muscle, C1

journal

Health impacts of eicosapentaenoic acid and docosahexaenoic acid

H Mateos, P Lewandowski, V Vaughan, X Su

(2013), Vol. 8, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, C1

journal

Marine polyunsaturated fatty acids and cancer therapy

V Vaughan, M Hassing, P Lewandowski

(2013), Vol. 108, pp. 486-492, British Journal of Cancer, C1

journal

Disruption of pro-oxidant and antioxidant systems with elevated expression of the ubiquitin proteosome system in the cachectic heart muscle of nude mice

E Hinch, M Sullivan-Gunn, V Vaughan, M McGlynn, P Lewandowski

(2013), Vol. 4, pp. 287-293, Journal of cachexia, sarcopenia and muscle, Berlin, Germany, C1-1

journal
2012

Eicosapentaenoic Acid and Oxypurinol in the Treatment of Muscle Wasting in a Mouse Model of Cancer Cachexia

V Vaughan, M Sullivan-Gunn, E Hinch, P Martin, P Lewandowski

(2012), Vol. 7, PLoS ONE, C1

journal

Funded Projects at Deakin

No Funded Projects at Deakin found

Supervisions

No completed student supervisions to report